nodes	percent_of_prediction	percent_of_DWPC	metapath
Molindone—HTR7—pulmonary artery—sarcoma	0.0748	0.194	CbGeAlD
Molindone—Pigmentation disorder—Thiotepa—sarcoma	0.0522	0.0849	CcSEcCtD
Molindone—HTR2A—pulmonary artery—sarcoma	0.0467	0.121	CbGeAlD
Molindone—Pigmentation disorder—Etoposide—sarcoma	0.0375	0.061	CcSEcCtD
Molindone—HTR2A—hindlimb—sarcoma	0.0282	0.0733	CbGeAlD
Molindone—Throat tightness—Etoposide—sarcoma	0.0255	0.0415	CcSEcCtD
Molindone—HTR2A—appendage—sarcoma	0.0242	0.0629	CbGeAlD
Molindone—HTR7—endothelium—sarcoma	0.0234	0.0609	CbGeAlD
Molindone—Extrapyramidal disorder—Thiotepa—sarcoma	0.0231	0.0376	CcSEcCtD
Molindone—Pigmentation disorder—Epirubicin—sarcoma	0.021	0.0342	CcSEcCtD
Molindone—Amenorrhoea—Thiotepa—sarcoma	0.0198	0.0323	CcSEcCtD
Molindone—Pigmentation disorder—Doxorubicin—sarcoma	0.0195	0.0316	CcSEcCtD
Molindone—Amenorrhoea—Mitoxantrone—sarcoma	0.0171	0.0279	CcSEcCtD
Molindone—HTR2A—endothelium—sarcoma	0.0146	0.038	CbGeAlD
Molindone—HTR1A—hematopoietic system—sarcoma	0.012	0.0313	CbGeAlD
Molindone—Urinary retention—Thiotepa—sarcoma	0.012	0.0196	CcSEcCtD
Molindone—HTR7—hematopoietic system—sarcoma	0.0115	0.0299	CbGeAlD
Molindone—HTR7—connective tissue—sarcoma	0.0111	0.0288	CbGeAlD
Molindone—Dysphagia—Dactinomycin—sarcoma	0.0109	0.0176	CcSEcCtD
Molindone—Urinary retention—Vincristine—sarcoma	0.0107	0.0173	CcSEcCtD
Molindone—HTR7—smooth muscle tissue—sarcoma	0.0101	0.0263	CbGeAlD
Molindone—Weight increased—Thiotepa—sarcoma	0.00995	0.0162	CcSEcCtD
Molindone—ADRA2A—myometrium—sarcoma	0.00983	0.0255	CbGeAlD
Molindone—ADRA2A—seminal vesicle—sarcoma	0.00888	0.0231	CbGeAlD
Molindone—Weight decreased—Vincristine—sarcoma	0.00877	0.0143	CcSEcCtD
Molindone—Weight increased—Mitoxantrone—sarcoma	0.0086	0.014	CcSEcCtD
Molindone—Weight decreased—Mitoxantrone—sarcoma	0.00854	0.0139	CcSEcCtD
Molindone—ADRA2A—hematopoietic system—sarcoma	0.00844	0.0219	CbGeAlD
Molindone—Drowsiness—Mitoxantrone—sarcoma	0.00842	0.0137	CcSEcCtD
Molindone—ADRA2A—connective tissue—sarcoma	0.00813	0.0211	CbGeAlD
Molindone—HTR2A—embryo—sarcoma	0.00804	0.0209	CbGeAlD
Molindone—Amenorrhoea—Epirubicin—sarcoma	0.00799	0.013	CcSEcCtD
Molindone—Dysphagia—Etoposide—sarcoma	0.00786	0.0128	CcSEcCtD
Molindone—HTR7—tendon—sarcoma	0.00762	0.0198	CbGeAlD
Molindone—Dyskinesia—Epirubicin—sarcoma	0.00747	0.0121	CcSEcCtD
Molindone—Amenorrhoea—Doxorubicin—sarcoma	0.00739	0.012	CcSEcCtD
Molindone—Vision blurred—Thiotepa—sarcoma	0.00718	0.0117	CcSEcCtD
Molindone—HTR2A—hematopoietic system—sarcoma	0.00718	0.0186	CbGeAlD
Molindone—Agitation—Thiotepa—sarcoma	0.007	0.0114	CcSEcCtD
Molindone—Dyskinesia—Doxorubicin—sarcoma	0.00691	0.0112	CcSEcCtD
Molindone—HTR2A—connective tissue—sarcoma	0.00691	0.0179	CbGeAlD
Molindone—Leukopenia—Thiotepa—sarcoma	0.00682	0.0111	CcSEcCtD
Molindone—Salivary hypersecretion—Epirubicin—sarcoma	0.00682	0.0111	CcSEcCtD
Molindone—Leukopenia—Dactinomycin—sarcoma	0.00677	0.011	CcSEcCtD
Molindone—ADRA2A—cardiac atrium—sarcoma	0.00641	0.0166	CbGeAlD
Molindone—ADRA2A—uterus—sarcoma	0.00637	0.0166	CbGeAlD
Molindone—HTR2A—smooth muscle tissue—sarcoma	0.00632	0.0164	CbGeAlD
Molindone—Salivary hypersecretion—Doxorubicin—sarcoma	0.00631	0.0103	CcSEcCtD
Molindone—HTR7—testis—sarcoma	0.00631	0.0164	CbGeAlD
Molindone—Agitation—Vincristine—sarcoma	0.00621	0.0101	CcSEcCtD
Molindone—Vision blurred—Mitoxantrone—sarcoma	0.0062	0.0101	CcSEcCtD
Molindone—Tachycardia—Thiotepa—sarcoma	0.00607	0.00987	CcSEcCtD
Molindone—Leukopenia—Vincristine—sarcoma	0.00605	0.00983	CcSEcCtD
Molindone—DRD2—testis—sarcoma	0.00596	0.0155	CbGeAlD
Molindone—HTR7—liver—sarcoma	0.00596	0.0155	CbGeAlD
Molindone—Leukopenia—Mitoxantrone—sarcoma	0.00589	0.00958	CcSEcCtD
Molindone—ADRA2A—tendon—sarcoma	0.00558	0.0145	CbGeAlD
Molindone—Somnolence—Thiotepa—sarcoma	0.00553	0.00899	CcSEcCtD
Molindone—Constipation—Thiotepa—sarcoma	0.00532	0.00865	CcSEcCtD
Molindone—Muscle spasms—Etoposide—sarcoma	0.00526	0.00856	CcSEcCtD
Molindone—Tachycardia—Mitoxantrone—sarcoma	0.00524	0.00852	CcSEcCtD
Molindone—Hypotension—Vincristine—sarcoma	0.00515	0.00838	CcSEcCtD
Molindone—Hypotension—Mitoxantrone—sarcoma	0.00502	0.00816	CcSEcCtD
Molindone—Leukopenia—Etoposide—sarcoma	0.0049	0.00797	CcSEcCtD
Molindone—Dyspnoea—Mitoxantrone—sarcoma	0.00479	0.00779	CcSEcCtD
Molindone—Somnolence—Mitoxantrone—sarcoma	0.00477	0.00776	CcSEcCtD
Molindone—HTR2A—tendon—sarcoma	0.00475	0.0123	CbGeAlD
Molindone—Constipation—Vincristine—sarcoma	0.00472	0.00767	CcSEcCtD
Molindone—ADRA2A—testis—sarcoma	0.00462	0.012	CbGeAlD
Molindone—Constipation—Mitoxantrone—sarcoma	0.00459	0.00747	CcSEcCtD
Molindone—Dysphagia—Epirubicin—sarcoma	0.0044	0.00716	CcSEcCtD
Molindone—Tachycardia—Etoposide—sarcoma	0.00436	0.00709	CcSEcCtD
Molindone—Hypotension—Etoposide—sarcoma	0.00417	0.00679	CcSEcCtD
Molindone—Dysphagia—Doxorubicin—sarcoma	0.00407	0.00663	CcSEcCtD
Molindone—Weight increased—Epirubicin—sarcoma	0.00401	0.00652	CcSEcCtD
Molindone—Weight decreased—Epirubicin—sarcoma	0.00398	0.00648	CcSEcCtD
Molindone—Dyspnoea—Etoposide—sarcoma	0.00398	0.00648	CcSEcCtD
Molindone—Somnolence—Etoposide—sarcoma	0.00397	0.00646	CcSEcCtD
Molindone—HTR2A—testis—sarcoma	0.00393	0.0102	CbGeAlD
Molindone—Drowsiness—Epirubicin—sarcoma	0.00393	0.00638	CcSEcCtD
Molindone—Rash—Thiotepa—sarcoma	0.00392	0.00638	CcSEcCtD
Molindone—Dermatitis—Thiotepa—sarcoma	0.00392	0.00637	CcSEcCtD
Molindone—Rash—Dactinomycin—sarcoma	0.00389	0.00633	CcSEcCtD
Molindone—Constipation—Etoposide—sarcoma	0.00382	0.00621	CcSEcCtD
Molindone—HTR2A—liver—sarcoma	0.00372	0.00966	CbGeAlD
Molindone—Weight increased—Doxorubicin—sarcoma	0.00371	0.00603	CcSEcCtD
Molindone—Nausea—Thiotepa—sarcoma	0.00369	0.00601	CcSEcCtD
Molindone—Weight decreased—Doxorubicin—sarcoma	0.00369	0.00599	CcSEcCtD
Molindone—Nausea—Dactinomycin—sarcoma	0.00367	0.00596	CcSEcCtD
Molindone—Drowsiness—Doxorubicin—sarcoma	0.00363	0.00591	CcSEcCtD
Molindone—Rash—Vincristine—sarcoma	0.00348	0.00565	CcSEcCtD
Molindone—Dermatitis—Vincristine—sarcoma	0.00347	0.00565	CcSEcCtD
Molindone—Rash—Mitoxantrone—sarcoma	0.00339	0.00551	CcSEcCtD
Molindone—Dermatitis—Mitoxantrone—sarcoma	0.00338	0.0055	CcSEcCtD
Molindone—ADRA2A—lymph node—sarcoma	0.00335	0.00871	CbGeAlD
Molindone—Nausea—Vincristine—sarcoma	0.00328	0.00533	CcSEcCtD
Molindone—Nausea—Mitoxantrone—sarcoma	0.00319	0.00519	CcSEcCtD
Molindone—Muscle spasms—Epirubicin—sarcoma	0.00295	0.0048	CcSEcCtD
Molindone—Vision blurred—Epirubicin—sarcoma	0.00289	0.0047	CcSEcCtD
Molindone—Agitation—Epirubicin—sarcoma	0.00282	0.00458	CcSEcCtD
Molindone—Rash—Etoposide—sarcoma	0.00282	0.00458	CcSEcCtD
Molindone—Dermatitis—Etoposide—sarcoma	0.00281	0.00458	CcSEcCtD
Molindone—Leukopenia—Epirubicin—sarcoma	0.00275	0.00447	CcSEcCtD
Molindone—Muscle spasms—Doxorubicin—sarcoma	0.00273	0.00444	CcSEcCtD
Molindone—Vision blurred—Doxorubicin—sarcoma	0.00268	0.00435	CcSEcCtD
Molindone—Nausea—Etoposide—sarcoma	0.00265	0.00431	CcSEcCtD
Molindone—Agitation—Doxorubicin—sarcoma	0.00261	0.00424	CcSEcCtD
Molindone—Dry mouth—Epirubicin—sarcoma	0.00255	0.00415	CcSEcCtD
Molindone—Leukopenia—Doxorubicin—sarcoma	0.00254	0.00413	CcSEcCtD
Molindone—Tachycardia—Epirubicin—sarcoma	0.00244	0.00397	CcSEcCtD
Molindone—Dry mouth—Doxorubicin—sarcoma	0.00236	0.00384	CcSEcCtD
Molindone—Hypotension—Epirubicin—sarcoma	0.00234	0.0038	CcSEcCtD
Molindone—Tachycardia—Doxorubicin—sarcoma	0.00226	0.00368	CcSEcCtD
Molindone—Dyspnoea—Epirubicin—sarcoma	0.00223	0.00363	CcSEcCtD
Molindone—Somnolence—Epirubicin—sarcoma	0.00223	0.00362	CcSEcCtD
Molindone—Hypotension—Doxorubicin—sarcoma	0.00217	0.00352	CcSEcCtD
Molindone—Constipation—Epirubicin—sarcoma	0.00214	0.00348	CcSEcCtD
Molindone—Dyspnoea—Doxorubicin—sarcoma	0.00207	0.00336	CcSEcCtD
Molindone—Somnolence—Doxorubicin—sarcoma	0.00206	0.00335	CcSEcCtD
Molindone—Constipation—Doxorubicin—sarcoma	0.00198	0.00322	CcSEcCtD
Molindone—Rash—Epirubicin—sarcoma	0.00158	0.00257	CcSEcCtD
Molindone—Dermatitis—Epirubicin—sarcoma	0.00158	0.00256	CcSEcCtD
Molindone—Nausea—Epirubicin—sarcoma	0.00149	0.00242	CcSEcCtD
Molindone—Rash—Doxorubicin—sarcoma	0.00146	0.00238	CcSEcCtD
Molindone—Dermatitis—Doxorubicin—sarcoma	0.00146	0.00237	CcSEcCtD
Molindone—Nausea—Doxorubicin—sarcoma	0.00138	0.00224	CcSEcCtD
